Global Paediatric Gliomas Drugs Market Growth 2022-2028
Paediatric gliomas is a type of disorder that is characterized by the tumour of spinal cord or brain in children. It starts in glial cells that are present around the neurons, generating electrical impulses to transmit information, commonly known as glioma tumour. Moreover, the tumour causes complete damage in infratentorial brain functioning, including the brainstem and cerebellum. The most common symptoms in gliomas tumours include vomiting, headache, nausea, vision problems, and seizures.
The global market for Paediatric Gliomas Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Paediatric Gliomas Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Paediatric Gliomas Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Paediatric Gliomas Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Paediatric Gliomas Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Paediatric Gliomas Drugs players cover Mylan N.V, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Paediatric Gliomas Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Paediatric Gliomas Drugs market, with both quantitative and qualitative data, to help readers understand how the Paediatric Gliomas Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Paediatric Gliomas Drugs market and forecasts the market size by Type (MTOR Inhibitors and MEK Blocker,), by Application (Hospital, Specialist Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
MTOR Inhibitors
MEK Blocker
Segmentation by application
Hospital
Specialist Clinic
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Mylan N.V
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
Novartis AG
Bayer AG
Merck & Co., Inc
AstraZeneca
Abbott
Bausch Health Companies Inc
Aurobindo Pharma
Lupin
Amneal Pharmaceuticals LLC
Sun Pharmaceutical Industries Ltd
Thermo Fisher Scientific Inc
Baxter
Hitachi, Ltd
Arbor Pharmaceuticals
Siemens Healthcare GmbH
Konninklije Philips N.V
Chapter Introduction
Chapter 1: Scope of Paediatric Gliomas Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Paediatric Gliomas Drugs market size (sales and revenue) and CAGR, Paediatric Gliomas Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Paediatric Gliomas Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Paediatric Gliomas Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Paediatric Gliomas Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Mylan N.V, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, Novartis AG, Bayer AG, Merck & Co., Inc, AstraZeneca and Abbott, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paediatric Gliomas Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Paediatric Gliomas Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Paediatric Gliomas Drugs by Country/Region, 2017, 2022 & 2028
2.2 Paediatric Gliomas Drugs Segment by Type
2.2.1 MTOR Inhibitors
2.2.2 MEK Blocker
2.3 Paediatric Gliomas Drugs Sales by Type
2.3.1 Global Paediatric Gliomas Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Paediatric Gliomas Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Paediatric Gliomas Drugs Sale Price by Type (2017-2022)
2.4 Paediatric Gliomas Drugs Segment by Application
2.4.1 Hospital
2.4.2 Specialist Clinic
2.4.3 Other
2.5 Paediatric Gliomas Drugs Sales by Application
2.5.1 Global Paediatric Gliomas Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Paediatric Gliomas Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Paediatric Gliomas Drugs Sale Price by Application (2017-2022)
3 Global Paediatric Gliomas Drugs by Company
3.1 Global Paediatric Gliomas Drugs Breakdown Data by Company
3.1.1 Global Paediatric Gliomas Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Paediatric Gliomas Drugs Sales Market Share by Company (2020-2022)
3.2 Global Paediatric Gliomas Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Paediatric Gliomas Drugs Revenue by Company (2020-2022)
3.2.2 Global Paediatric Gliomas Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Paediatric Gliomas Drugs Sale Price by Company
3.4 Key Manufacturers Paediatric Gliomas Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paediatric Gliomas Drugs Product Location Distribution
3.4.2 Players Paediatric Gliomas Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Paediatric Gliomas Drugs by Geographic Region
4.1 World Historic Paediatric Gliomas Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Paediatric Gliomas Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Paediatric Gliomas Drugs Annual Revenue by Geographic Region
4.2 World Historic Paediatric Gliomas Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Paediatric Gliomas Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Paediatric Gliomas Drugs Annual Revenue by Country/Region
4.3 Americas Paediatric Gliomas Drugs Sales Growth
4.4 APAC Paediatric Gliomas Drugs Sales Growth
4.5 Europe Paediatric Gliomas Drugs Sales Growth
4.6 Middle East & Africa Paediatric Gliomas Drugs Sales Growth
5 Americas
5.1 Americas Paediatric Gliomas Drugs Sales by Country
5.1.1 Americas Paediatric Gliomas Drugs Sales by Country (2017-2022)
5.1.2 Americas Paediatric Gliomas Drugs Revenue by Country (2017-2022)
5.2 Americas Paediatric Gliomas Drugs Sales by Type
5.3 Americas Paediatric Gliomas Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paediatric Gliomas Drugs Sales by Region
6.1.1 APAC Paediatric Gliomas Drugs Sales by Region (2017-2022)
6.1.2 APAC Paediatric Gliomas Drugs Revenue by Region (2017-2022)
6.2 APAC Paediatric Gliomas Drugs Sales by Type
6.3 APAC Paediatric Gliomas Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Paediatric Gliomas Drugs by Country
7.1.1 Europe Paediatric Gliomas Drugs Sales by Country (2017-2022)
7.1.2 Europe Paediatric Gliomas Drugs Revenue by Country (2017-2022)
7.2 Europe Paediatric Gliomas Drugs Sales by Type
7.3 Europe Paediatric Gliomas Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Paediatric Gliomas Drugs by Country
8.1.1 Middle East & Africa Paediatric Gliomas Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Paediatric Gliomas Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Paediatric Gliomas Drugs Sales by Type
8.3 Middle East & Africa Paediatric Gliomas Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paediatric Gliomas Drugs
10.3 Manufacturing Process Analysis of Paediatric Gliomas Drugs
10.4 Industry Chain Structure of Paediatric Gliomas Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paediatric Gliomas Drugs Distributors
11.3 Paediatric Gliomas Drugs Customer
12 World Forecast Review for Paediatric Gliomas Drugs by Geographic Region
12.1 Global Paediatric Gliomas Drugs Market Size Forecast by Region
12.1.1 Global Paediatric Gliomas Drugs Forecast by Region (2023-2028)
12.1.2 Global Paediatric Gliomas Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Paediatric Gliomas Drugs Forecast by Type
12.7 Global Paediatric Gliomas Drugs Forecast by Application
13 Key Players Analysis
13.1 Mylan N.V
13.1.1 Mylan N.V Company Information
13.1.2 Mylan N.V Paediatric Gliomas Drugs Product Offered
13.1.3 Mylan N.V Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mylan N.V Main Business Overview
13.1.5 Mylan N.V Latest Developments
13.2 Teva Pharmaceutical Industries Ltd
13.2.1 Teva Pharmaceutical Industries Ltd Company Information
13.2.2 Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Product Offered
13.2.3 Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Paediatric Gliomas Drugs Product Offered
13.3.3 Sanofi Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Paediatric Gliomas Drugs Product Offered
13.4.3 Pfizer Inc Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Paediatric Gliomas Drugs Product Offered
13.5.3 Novartis AG Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Bayer AG
13.6.1 Bayer AG Company Information
13.6.2 Bayer AG Paediatric Gliomas Drugs Product Offered
13.6.3 Bayer AG Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bayer AG Main Business Overview
13.6.5 Bayer AG Latest Developments
13.7 Merck & Co., Inc
13.7.1 Merck & Co., Inc Company Information
13.7.2 Merck & Co., Inc Paediatric Gliomas Drugs Product Offered
13.7.3 Merck & Co., Inc Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck & Co., Inc Main Business Overview
13.7.5 Merck & Co., Inc Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Paediatric Gliomas Drugs Product Offered
13.8.3 AstraZeneca Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Paediatric Gliomas Drugs Product Offered
13.9.3 Abbott Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 Bausch Health Companies Inc
13.10.1 Bausch Health Companies Inc Company Information
13.10.2 Bausch Health Companies Inc Paediatric Gliomas Drugs Product Offered
13.10.3 Bausch Health Companies Inc Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bausch Health Companies Inc Main Business Overview
13.10.5 Bausch Health Companies Inc Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Paediatric Gliomas Drugs Product Offered
13.11.3 Aurobindo Pharma Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Lupin
13.12.1 Lupin Company Information
13.12.2 Lupin Paediatric Gliomas Drugs Product Offered
13.12.3 Lupin Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Lupin Main Business Overview
13.12.5 Lupin Latest Developments
13.13 Amneal Pharmaceuticals LLC
13.13.1 Amneal Pharmaceuticals LLC Company Information
13.13.2 Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Product Offered
13.13.3 Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Amneal Pharmaceuticals LLC Main Business Overview
13.13.5 Amneal Pharmaceuticals LLC Latest Developments
13.14 Sun Pharmaceutical Industries Ltd
13.14.1 Sun Pharmaceutical Industries Ltd Company Information
13.14.2 Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Product Offered
13.14.3 Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sun Pharmaceutical Industries Ltd Main Business Overview
13.14.5 Sun Pharmaceutical Industries Ltd Latest Developments
13.15 Thermo Fisher Scientific Inc
13.15.1 Thermo Fisher Scientific Inc Company Information
13.15.2 Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Product Offered
13.15.3 Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Thermo Fisher Scientific Inc Main Business Overview
13.15.5 Thermo Fisher Scientific Inc Latest Developments
13.16 Baxter
13.16.1 Baxter Company Information
13.16.2 Baxter Paediatric Gliomas Drugs Product Offered
13.16.3 Baxter Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Baxter Main Business Overview
13.16.5 Baxter Latest Developments
13.17 Hitachi, Ltd
13.17.1 Hitachi, Ltd Company Information
13.17.2 Hitachi, Ltd Paediatric Gliomas Drugs Product Offered
13.17.3 Hitachi, Ltd Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Hitachi, Ltd Main Business Overview
13.17.5 Hitachi, Ltd Latest Developments
13.18 Arbor Pharmaceuticals
13.18.1 Arbor Pharmaceuticals Company Information
13.18.2 Arbor Pharmaceuticals Paediatric Gliomas Drugs Product Offered
13.18.3 Arbor Pharmaceuticals Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Arbor Pharmaceuticals Main Business Overview
13.18.5 Arbor Pharmaceuticals Latest Developments
13.19 Siemens Healthcare GmbH
13.19.1 Siemens Healthcare GmbH Company Information
13.19.2 Siemens Healthcare GmbH Paediatric Gliomas Drugs Product Offered
13.19.3 Siemens Healthcare GmbH Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Siemens Healthcare GmbH Main Business Overview
13.19.5 Siemens Healthcare GmbH Latest Developments
13.20 Konninklije Philips N.V
13.20.1 Konninklije Philips N.V Company Information
13.20.2 Konninklije Philips N.V Paediatric Gliomas Drugs Product Offered
13.20.3 Konninklije Philips N.V Paediatric Gliomas Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Konninklije Philips N.V Main Business Overview
13.20.5 Konninklije Philips N.V Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Paediatric Gliomas Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Paediatric Gliomas Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of MTOR Inhibitors
Table 4. Major Players of MEK Blocker
Table 5. Global Paediatric Gliomas Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Paediatric Gliomas Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Paediatric Gliomas Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Paediatric Gliomas Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Paediatric Gliomas Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Paediatric Gliomas Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Paediatric Gliomas Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Paediatric Gliomas Drugs Revenue by Application (2017-2022)
Table 13. Global Paediatric Gliomas Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Paediatric Gliomas Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Paediatric Gliomas Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Paediatric Gliomas Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Paediatric Gliomas Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Paediatric Gliomas Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Paediatric Gliomas Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Paediatric Gliomas Drugs Producing Area Distribution and Sales Area
Table 21. Players Paediatric Gliomas Drugs Products Offered
Table 22. Paediatric Gliomas Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Paediatric Gliomas Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Paediatric Gliomas Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Paediatric Gliomas Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Paediatric Gliomas Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Paediatric Gliomas Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Paediatric Gliomas Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Paediatric Gliomas Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Paediatric Gliomas Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Paediatric Gliomas Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Paediatric Gliomas Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Paediatric Gliomas Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Paediatric Gliomas Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Paediatric Gliomas Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Paediatric Gliomas Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Paediatric Gliomas Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Paediatric Gliomas Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Paediatric Gliomas Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Paediatric Gliomas Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Paediatric Gliomas Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Paediatric Gliomas Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Paediatric Gliomas Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Paediatric Gliomas Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Paediatric Gliomas Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Paediatric Gliomas Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Paediatric Gliomas Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Paediatric Gliomas Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Paediatric Gliomas Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Paediatric Gliomas Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Paediatric Gliomas Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Paediatric Gliomas Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Paediatric Gliomas Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Paediatric Gliomas Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Paediatric Gliomas Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Paediatric Gliomas Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Paediatric Gliomas Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Paediatric Gliomas Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Paediatric Gliomas Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Paediatric Gliomas Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Paediatric Gliomas Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Paediatric Gliomas Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Paediatric Gliomas Drugs
Table 66. Key Market Challenges & Risks of Paediatric Gliomas Drugs
Table 67. Key Industry Trends of Paediatric Gliomas Drugs
Table 68. Paediatric Gliomas Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Paediatric Gliomas Drugs Distributors List
Table 71. Paediatric Gliomas Drugs Customer List
Table 72. Global Paediatric Gliomas Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Paediatric Gliomas Drugs Sales Market Forecast by Region
Table 74. Global Paediatric Gliomas Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Paediatric Gliomas Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Paediatric Gliomas Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Paediatric Gliomas Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Paediatric Gliomas Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Paediatric Gliomas Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Paediatric Gliomas Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Paediatric Gliomas Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Paediatric Gliomas Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Paediatric Gliomas Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Paediatric Gliomas Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Paediatric Gliomas Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Paediatric Gliomas Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Paediatric Gliomas Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Paediatric Gliomas Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Paediatric Gliomas Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Paediatric Gliomas Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Paediatric Gliomas Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Mylan N.V Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan N.V Paediatric Gliomas Drugs Product Offered
Table 94. Mylan N.V Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Mylan N.V Main Business
Table 96. Mylan N.V Latest Developments
Table 97. Teva Pharmaceutical Industries Ltd Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Product Offered
Table 99. Teva Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Teva Pharmaceutical Industries Ltd Main Business
Table 101. Teva Pharmaceutical Industries Ltd Latest Developments
Table 102. Sanofi Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Paediatric Gliomas Drugs Product Offered
Table 104. Sanofi Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Pfizer Inc Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Inc Paediatric Gliomas Drugs Product Offered
Table 109. Pfizer Inc Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Pfizer Inc Main Business
Table 111. Pfizer Inc Latest Developments
Table 112. Novartis AG Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Novartis AG Paediatric Gliomas Drugs Product Offered
Table 114. Novartis AG Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Novartis AG Main Business
Table 116. Novartis AG Latest Developments
Table 117. Bayer AG Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Bayer AG Paediatric Gliomas Drugs Product Offered
Table 119. Bayer AG Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Bayer AG Main Business
Table 121. Bayer AG Latest Developments
Table 122. Merck & Co., Inc Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Merck & Co., Inc Paediatric Gliomas Drugs Product Offered
Table 124. Merck & Co., Inc Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Merck & Co., Inc Main Business
Table 126. Merck & Co., Inc Latest Developments
Table 127. AstraZeneca Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. AstraZeneca Paediatric Gliomas Drugs Product Offered
Table 129. AstraZeneca Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. AstraZeneca Main Business
Table 131. AstraZeneca Latest Developments
Table 132. Abbott Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Abbott Paediatric Gliomas Drugs Product Offered
Table 134. Abbott Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Abbott Main Business
Table 136. Abbott Latest Developments
Table 137. Bausch Health Companies Inc Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Bausch Health Companies Inc Paediatric Gliomas Drugs Product Offered
Table 139. Bausch Health Companies Inc Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Bausch Health Companies Inc Main Business
Table 141. Bausch Health Companies Inc Latest Developments
Table 142. Aurobindo Pharma Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Aurobindo Pharma Paediatric Gliomas Drugs Product Offered
Table 144. Aurobindo Pharma Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Aurobindo Pharma Main Business
Table 146. Aurobindo Pharma Latest Developments
Table 147. Lupin Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Lupin Paediatric Gliomas Drugs Product Offered
Table 149. Lupin Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Lupin Main Business
Table 151. Lupin Latest Developments
Table 152. Amneal Pharmaceuticals LLC Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Product Offered
Table 154. Amneal Pharmaceuticals LLC Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Amneal Pharmaceuticals LLC Main Business
Table 156. Amneal Pharmaceuticals LLC Latest Developments
Table 157. Sun Pharmaceutical Industries Ltd Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Product Offered
Table 159. Sun Pharmaceutical Industries Ltd Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Sun Pharmaceutical Industries Ltd Main Business
Table 161. Sun Pharmaceutical Industries Ltd Latest Developments
Table 162. Thermo Fisher Scientific Inc Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Product Offered
Table 164. Thermo Fisher Scientific Inc Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Thermo Fisher Scientific Inc Main Business
Table 166. Thermo Fisher Scientific Inc Latest Developments
Table 167. Baxter Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Baxter Paediatric Gliomas Drugs Product Offered
Table 169. Baxter Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Baxter Main Business
Table 171. Baxter Latest Developments
Table 172. Hitachi, Ltd Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Hitachi, Ltd Paediatric Gliomas Drugs Product Offered
Table 174. Hitachi, Ltd Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Hitachi, Ltd Main Business
Table 176. Hitachi, Ltd Latest Developments
Table 177. Arbor Pharmaceuticals Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. Arbor Pharmaceuticals Paediatric Gliomas Drugs Product Offered
Table 179. Arbor Pharmaceuticals Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Arbor Pharmaceuticals Main Business
Table 181. Arbor Pharmaceuticals Latest Developments
Table 182. Siemens Healthcare GmbH Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Siemens Healthcare GmbH Paediatric Gliomas Drugs Product Offered
Table 184. Siemens Healthcare GmbH Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Siemens Healthcare GmbH Main Business
Table 186. Siemens Healthcare GmbH Latest Developments
Table 187. Konninklije Philips N.V Basic Information, Paediatric Gliomas Drugs Manufacturing Base, Sales Area and Its Competitors
Table 188. Konninklije Philips N.V Paediatric Gliomas Drugs Product Offered
Table 189. Konninklije Philips N.V Paediatric Gliomas Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Konninklije Philips N.V Main Business
Table 191. Konninklije Philips N.V Latest Developments
List of Figures
Figure 1. Picture of Paediatric Gliomas Drugs
Figure 2. Paediatric Gliomas Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paediatric Gliomas Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Paediatric Gliomas Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Paediatric Gliomas Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of MTOR Inhibitors
Figure 10. Product Picture of MEK Blocker
Figure 11. Global Paediatric Gliomas Drugs Sales Market Share by Type in 2021
Figure 12. Global Paediatric Gliomas Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Paediatric Gliomas Drugs Consumed in Hospital
Figure 14. Global Paediatric Gliomas Drugs Market: Hospital (2017-2022) & (K Units)
Figure 15. Paediatric Gliomas Drugs Consumed in Specialist Clinic
Figure 16. Global Paediatric Gliomas Drugs Market: Specialist Clinic (2017-2022) & (K Units)
Figure 17. Paediatric Gliomas Drugs Consumed in Other
Figure 18. Global Paediatric Gliomas Drugs Market: Other (2017-2022) & (K Units)
Figure 19. Global Paediatric Gliomas Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Paediatric Gliomas Drugs Revenue Market Share by Application in 2021
Figure 21. Paediatric Gliomas Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Paediatric Gliomas Drugs Revenue Market Share by Company in 2021
Figure 23. Global Paediatric Gliomas Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Paediatric Gliomas Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Paediatric Gliomas Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Paediatric Gliomas Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Paediatric Gliomas Drugs Sales 2017-2022 (K Units)
Figure 28. Americas Paediatric Gliomas Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Paediatric Gliomas Drugs Sales 2017-2022 (K Units)
Figure 30. APAC Paediatric Gliomas Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Paediatric Gliomas Drugs Sales 2017-2022 (K Units)
Figure 32. Europe Paediatric Gliomas Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Paediatric Gliomas Drugs Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Paediatric Gliomas Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Paediatric Gliomas Drugs Sales Market Share by Country in 2021
Figure 36. Americas Paediatric Gliomas Drugs Revenue Market Share by Country in 2021
Figure 37. United States Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Paediatric Gliomas Drugs Sales Market Share by Region in 2021
Figure 42. APAC Paediatric Gliomas Drugs Revenue Market Share by Regions in 2021
Figure 43. China Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Paediatric Gliomas Drugs Sales Market Share by Country in 2021
Figure 50. Europe Paediatric Gliomas Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Paediatric Gliomas Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Paediatric Gliomas Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Paediatric Gliomas Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Paediatric Gliomas Drugs in 2021
Figure 64. Manufacturing Process Analysis of Paediatric Gliomas Drugs
Figure 65. Industry Chain Structure of Paediatric Gliomas Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets